Results 151 to 160 of about 429,667 (356)

Contribution of molecular-modified biomimetic mesoporous silica xerogel in delivering nimesulide with superior anti-inflammatory efficacy

Journal of Materials Science: Materials in Medicine
High efficiency of anti-inflammatories for anti-inflammatory drugs has enormous room for improvement, aiming to reduce side effects. Herein, molecular-modified biomimetic mesoporous silica xerogel was applied to establish a superior carrier for ...
Liu Yang, Nan Yan, Jing Li
doaj   +1 more source

Electrosprayed Chitosan Nanoparticles for Drug Carriers in Cancer Treatment - A Mini Review

, 2023
Fatoni Udaneni, Muchfi Azizah, Dewanto Harjunowibowo, Mohammad Alauhdin, Peni Indrayudha, Yulianto Agung Rezeki   +5 more
openalex   +1 more source

A novel Malonamide Periodic Mesoporous Organosilica (PMO) for controlled Ibuprofen release [PDF]

, 2015
Controlled drug release gained a sharply increasing interest over recent years. Multiple materials have been screened as possible drug carriers, ranging from biodegradable polymers to hydroxyapatite[1].
Clerick, Sander, De Canck, Els, De Clercq, Jeriffa, Libbrecht, Wannes, van den Berg, Otto, Van Der Voort, Pascal   +5 more
core  

Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting

Molecular Oncology, EarlyView.
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia, Noelia Moares, Wenjie Yi‐He, Rosa Luna‐Espejo, Ricardo Fernandez‐Cisnal, Javier Ocaña‐Cuesta, Juan P. Muñoz‐Miranda, Antonio Gabucio, Cecilia M. Fernandez‐Ponce, Francisco Garcia‐Cozar   +9 more
wiley   +1 more source

Covalent organic frameworks (COFs) as carrier for improved drug delivery and biosensing applications [PDF]

Rida Younas, Farhat Jubeen, N. Bano, Silvana Andreescu, Zhang Hong-xia, Akhtar Hayat   +5 more
openalex   +1 more source

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

Molecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz, Anna L. Bartkowiak, Michael Rose, Nora Kolks, Patrick Petzsch, Vandana Solanki, Anne Stoffel, Bianca Faßbender, Leandra Lepping, Julka Volkamer, Karl Köhrer, Marc Seifert, Tokameh Mahmoudi, Tahlita C. M. Zuiverloon, Günter Niegisch, Michèle J. Hoffmann   +15 more
wiley   +1 more source

Chemical robotics — chemotactic drug carriers

Open Medicine, 2013
Lagzi István
doaj   +1 more source

Aerodynamic Factors Responsible for the Deaggregation of Carrier-Free Drug Powders to Form Micrometer and Submicrometer Aerosols

, 2013
P. Worth Longest, Yoen‐Ju Son, Landon T. Holbrook, Michael Hindle   +3 more
openalex   +1 more source

Optimization and in-vitro Evaluation of Poly (lactic acid) /Mesalazine Microspheres as Drug Carriers [PDF]

, 2017
Wafa Banabid, Djerboua Ferhat, Amor Maïza, Zineb Elbahri, Milad Baitiche   +4 more
openalex   +1 more source

Formulation of Metal–Organic Framework-Based Drug Carriers by Controlled Coordination of Methoxy PEG Phosphate: Boosting Colloidal Stability and Redispersibility

, 2021
Xu Chen, Yunhui Zhuang, Nakul Rampal, Rachel E. Hewitt, Giorgio Divitini, Christopher A. O’Keefe, Xiewen Liu, Daniel J. Whitaker, John W. Wills, Ravin Jugdaohsingh, Jonathan J. Powell, Han Yu, Clare P. Grey, Oren A. Scherman, David Fairen‐Jiménez   +14 more
openalex   +1 more source